Year: 2018

Building TreatGx Logic Trees for Personalized Prescribing Options

TreatGx is an evidence-based medication decision support system that provides personalized prescribing options for the management of common conditions. TreatGx logic trees include: 1. status of the condition being treated 2. previous non-pharmacological and pharmacological treatment(s) 3. current non-pharmacological and pharmacological…

Read More

Thrilled to have been invited to present at MedCity Engage in San Diego

We are thrilled to be selected to present our leading precision prescribing solution at MedCity Engage in San Diego on November 7th, 2018. During the contest at MedCity ENGAGE, promising startups offering innovative approaches and tackling the biggest problems in patient…

Read More

Minimum Pharmacogenetics Testing Panel for Psychotropic Medication

Bousman et al propose a minimum gene and allele set for pharmacogenetic testing in psychiatry that includes 16 variant alleles within five genes (CYP2C9, CYP2C19, CYP2D6, HLA-A,HLA-B). Genotype-guided prescribing with pharmacogenetics helps clinicians choose the right medication or dose for each…

Read More

GenXys selected to present at the Healthcare Revolution conference in Orlando, Florida

We are thrilled to be selected to present our leading precision prescribing solution at the Healthcare Revolution conference in Orlando, Florida on October 28th, 2018. Global Healthcare Ventures joined forces with Global Healthcare Resources to showcase companies with high-growth market potential….

Read More

New TreatGx upgrade: drug-drug interaction checker built right into the precision prescribing software

We are excited to announce the release of the new drug-drug interaction checker built right into the TreatGx software! The checker is powered by DrugBank, a comprehensive drug database containing more than 280,000 drug-drug interactions. The upgrade includes an easier-to-use interface…

Read More

Leader in precision prescribing ready to expand software and pharmacogenetic test globally after making its mark in Canada

GenXys, a precision prescribing software company tackling a $130 billion global problem, has announced plans to expand into new regions to improve patient safety, medication effectiveness and healthcare costs around the globe Vancouver, August 30, 2018. In response to increased demand…

Read More

TreatGx medication decision support software helps clinicians to more accurately dose ADHD medications

The new ADHD algorithm in the TreatGx medication decision support software helps clinicians to more accurately dose ADHD medications. Attention deficit hyperactivity disorder (ADHD) is a mental disorder characterized by an ongoing pattern of behavioral symptoms that include inattentiveness, hyperactivity, and…

Read More

CNV testing should be universally used in clinical genetic testing

Your DNA holds instructions for everything your body needs to do, from determining the color of your eyes to breaking down medications. Each person’s genome is a unique combination of DNA sequences and structural variations that play major roles in determining…

Read More

Health Canada recalls blood-pressure drug valsartan due to contamination with potential carcinogen

Millions of Canadians affected by Health Canada’s recall of valsartan are being asked to contact their pharmacist as soon as possible to make a drug substitution. Health Canada announced that numerous varieties of valsartan, a generic drug sold by several companies…

Read More

New CEO of health enterprise by Amazon, Berkshire Hathaway & JPMorgan, Atul Gawande, on electronic prescribing

Surgeon, public health researcher, and author Atul Gawande is the new CEO of the health enterprise by Amazon, Berkshire Hathaway and JPMorgan. Gawande hopes to lower healthcare costs without raising risk, by helping professionals “make it simpler to do the right…

Read More